In our study, we found upregulation in the expression of HSPD1 mRNA with discriminative cutoff values between NASH cases and the healthy control group that could also discriminate between NAFLD without steatosis, NAFLD with simple steatosis and NASH cases. Here, HSPD1 is linked to metabolic dysfunction-associated steatotic liver disease.